Tenaya Therapeutics

TNYA · NASDAQ🇺🇸

Overview

Earnings Dividends Seasonality Metrics

Reported earnings 12 days ago

Previous year: -$0.61

-34.4%

Research and Development Expenses

$22.9M

General and Administrative Expenses

$8.58M

Net Loss Per Share, Basic and Diluted

Previous year: -$23.5M

Loading...

Tenaya Therapeutics

Unlock previous datapoints

Upgrade

Tenaya Therapeutics

Unlock previous datapoints

Upgrade

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$135M

P/E Ratio

-0.74

Sector

N/A

Industry

N/A

52-Week High

$2.07

52-Week Low

$0.36

Research and Development Expenses

$22.9M

General and Administrative Expenses

$8.58M

Net Loss Per Share, Basic and Diluted

-$0.4

Total Operating Expenses

$31.4M

Interest Income

$1.47M

Products

Get in Touch

Resources

Tenaya Therapeutics

Tenaya Therapeutics

Tenaya Therapeutics

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics